meanwhile, our financial profile has remained solid throughout the change in consumer purchasing patterns, and we generated record earnings per share of $num-one and free cash flow of approximately $num-two million in qtr-one.
diluted earnings per share for the quarter was a record $num-one per share, up over num-two% versus the prior year driven by both the higher sales discussed and lower interest expense.
lastly, record diluted earnings per share of $num-one grew num-two% over the prior year.
qtr-one revenue of $num-one million increased num-two% and num-three% on an organic basis versus the prior year, the latter excluding the effect of foreign currency.
looking forward, we now anticipate interest for the full year to approximate $num-one million, reflecting the recent financing completed in conjunction with the theratears acquisition.
we anticipate adjusted earnings per share of $num-one or more for fiscal year-seven.